Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Anticholinergic serum levels and cognitive performance.

O J Thienhaus¹, A Allen, J A Bennett

¹Department of Psychiatry, University of Cincinnati, OH 45267-0559.

European Archives of Psychiatry and Clinical Neuroscience

|January 1, 1990

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Using electrical impedance tomography to estimate tidal volume in bottlenose dolphins and cape fur seals in seawater and on land.

The Journal of experimental biology·2026

Same author

Loss of tight junction protein claudin 18 uncovers alveolar epithelial stem cell plasticity and emergence of non-fibrogenic transitional progenitors.

bioRxiv : the preprint server for biology·2025

Same author

Effect on compression of lowering the design adiabat in the SQ-n campaign.

Physical review. E·2025

Same author

First Demonstration of Improved Fusion Yield with Increased Compression through Reduced Adiabat in Inertial Confinement Fusion Experiments at the National Ignition Facility.

Physical review letters·2025

Same author

Early adaptive schemas, emotional regulation, and cognitive flexibility in eating disorders: subtype specific predictors of eating disorder symptoms using hierarchical linear regression.

Eating and weight disorders : EWD·2024

Same author

Design of the first fusion experiment to achieve target energy gain G>1.

Physical review. E·2024

Same journal

Abnormal emotional intensity processing in individuals at clinical high risk for psychosis: evidence from event-related potentials.

European archives of psychiatry and clinical neuroscience·2026

Same journal

The role of attention in perceptual biases in patients with schizophrenia spectrum disorder and healthy controls.

European archives of psychiatry and clinical neuroscience·2026

Same journal

Effects of quetiapine on cognitive functioning in schizophrenia: evidence for the remyelination hypothesis?

European archives of psychiatry and clinical neuroscience·2026

Same journal

Effects of xanomeline-trospium on the gut-lung microbiota axis and susceptibility to LPS-induced acute lung injury in male and female mice.

European archives of psychiatry and clinical neuroscience·2026

Same journal

Association of the red blood cell distribution width-to-albumin ratio with incident depression and depressive symptom trajectories in older adults.

European archives of psychiatry and clinical neuroscience·2026

Same journal

Major depressive disorder-alcohol use disorder comorbidity: diagnosis, mechanisms and treatment.

European archives of psychiatry and clinical neuroscience·2026

See all related articles

Central cholinergic neurotransmission is vital for cognition. Anticholinergic medications can impair cognitive function, especially in Alzheimer's disease patients, necessitating careful monitoring in geriatric psychopharmacotherapy.

Area of Science:

Neuroscience
Geriatric Psychiatry
Pharmacology

Background:

Central cholinergic neurotransmission is crucial for cognitive functions.
Many psychotherapeutic drugs possess anticholinergic side effects.
Assessing the impact of these side effects on cognition is important in elderly patients.

Purpose of the Study:

To investigate the effect of anticholinergic activity on cognitive performance in geropsychiatric patients.
To differentiate the cognitive impact of anticholinergic activity between patients with and without Alzheimer's disease.

Main Methods:

Cognitive testing was performed on 28 geropsychiatric inpatients.
Testing was conducted at varying levels of anticholinergic serum activity.
Patients were categorized into those with probable Alzheimer's disease and non-demented individuals.

Related Experiment Videos

Main Results:

Deterioration in cognitive functions was observed in Alzheimer's disease patients at specific anticholinergic serum levels.
Non-demented patients showed no significant cognitive dysfunction at similar anticholinergic serum levels.
Elderly psychiatric patients without dementia tolerated psychotropic medications better cognitively.

Conclusions:

Non-demented elderly patients with psychiatric issues can generally tolerate psychotropic pharmacotherapy without significant cognitive impairment.
Patients with Alzheimer's disease are at increased risk of cognitive decline due to anticholinergic effects.
Anticholinergic serum activity monitoring may be a useful tool for safe psychopharmacotherapy in geriatric patients.